Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 402, pseudogene (RN7SL402P) is a pseudogene of the 7SL RNA gene family in humans[1][5][6][7]. The 7SL RNA is a non-coding RNA component of the signal recognition particle, essential for directing secretory proteins to the endoplasmic reticulum, but pseudogenes like RN7SL402P are non-functional, arising from reverse-transcribed 7SL RNA sequences inserted back into the genome[1][5][6][7]. The majority of 7SL-related sequences in the human genome are such pseudogenes, which are generally not transcribed or translated and have no known biological or disease-related function[6][7]. RN7SL402P is not a therapeutic target, enzyme, transporter, or receptor; it should not be considered a molecular target in pharmacological or diagnostic contexts[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 402, pseudogene (RN7SL402P).